LFG Wealth Partners LLC Buys Shares of 1,326 Humana Inc. $HUM

LFG Wealth Partners LLC purchased a new stake in Humana Inc. (NYSE:HUM) in the 4th quarter, HoldingsChannel.com reports. The institutional investor purchased 1,326 shares of the insurance provider’s stock, valued at approximately $340,000.

A number of other hedge funds and other institutional investors have also made changes to their positions in HUM. Long Focus Capital Management LLC acquired a new position in shares of Humana in the 3rd quarter valued at $34,212,000. AMG National Trust Bank grew its holdings in shares of Humana by 106.5% during the 3rd quarter. AMG National Trust Bank now owns 16,953 shares of the insurance provider’s stock worth $4,411,000 after purchasing an additional 8,744 shares during the period. Aberdeen Group plc raised its holdings in Humana by 18.1% in the 4th quarter. Aberdeen Group plc now owns 283,778 shares of the insurance provider’s stock valued at $72,684,000 after buying an additional 43,442 shares during the period. Alberta Investment Management Corp acquired a new stake in shares of Humana during the third quarter valued at about $4,735,000. Finally, Mitsubishi UFJ Asset Management Co. Ltd. raised its stake in shares of Humana by 4.1% in the 4th quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 250,330 shares of the insurance provider’s stock valued at $66,207,000 after acquiring an additional 9,960 shares during the period. Institutional investors and hedge funds own 92.38% of the company’s stock.

Humana Price Performance

Shares of NYSE:HUM opened at $380.27 on Tuesday. Humana Inc. has a 12 month low of $163.11 and a 12 month high of $380.79. The firm has a market capitalization of $45.66 billion, a price-to-earnings ratio of 40.67, a price-to-earnings-growth ratio of 2.16 and a beta of 0.76. The business’s 50 day simple moving average is $271.95 and its 200-day simple moving average is $238.26. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.77 and a quick ratio of 1.77.

Humana (NYSE:HUM) last issued its quarterly earnings data on Wednesday, April 29th. The insurance provider reported $10.31 earnings per share (EPS) for the quarter, topping the consensus estimate of $9.97 by $0.34. The firm had revenue of $39.65 billion during the quarter, compared to analysts’ expectations of $39.37 billion. Humana had a return on equity of 10.45% and a net margin of 0.82%.Humana’s revenue was up 23.5% on a year-over-year basis. During the same period in the previous year, the firm posted $11.58 earnings per share. Humana has set its FY 2026 guidance at 9.000- EPS. As a group, equities analysts forecast that Humana Inc. will post 9.04 earnings per share for the current fiscal year.

Humana Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Friday, June 26th will be issued a dividend of $0.885 per share. This represents a $3.54 dividend on an annualized basis and a yield of 0.9%. The ex-dividend date is Friday, June 26th. Humana’s dividend payout ratio is 37.86%.

Analysts Set New Price Targets

Several equities analysts recently issued reports on HUM shares. Zacks Research raised Humana from a “strong sell” rating to a “hold” rating in a research note on Wednesday, May 13th. Truist Financial upped their price objective on shares of Humana from $270.00 to $320.00 and gave the company a “hold” rating in a research note on Monday, June 1st. Leerink Partners upped their target price on Humana from $185.00 to $255.00 and gave the company a “market perform” rating in a research report on Thursday, April 30th. Piper Sandler reaffirmed a “neutral” rating and set a $254.00 price target (up from $182.00) on shares of Humana in a research report on Wednesday, May 13th. Finally, Weiss Ratings upgraded shares of Humana from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Friday. One investment analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, sixteen have assigned a Hold rating and three have given a Sell rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and an average price target of $291.35.

Humana Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.